meganuclease

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – French firm Cellectis and North Carolina-based Precision Biosciences have filed two new suits against each other alleging infringement of US patents covering modified meganucleases.

Helix will promote Cellectis' Genome Positioning System line of products and services in India.

The French firm gains access to Cyto Pulse's electroporation technologies and equipment.

Cedarlane will distribute Cellectis Bioresearch's kits in Canada.

The patent has been the subject of ongoing litigation between the French and US biotech firms.

The agricultural products company will use Cellectis' meganuclease tools and will invest in the French firm.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.